FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328049239> ?p ?o ?g. }

• W4328049239 endingPage "e929" @default.
• W4328049239 startingPage "e921" @default.
• W4328049239 abstract "In the South African Breast Cancer and HIV Outcomes (SABCHO) study, we previously found that breast cancer patients living with HIV and treated with neoadjuvant chemotherapy achieve lower rates of complete pathologic response than patients without HIV. We now assess the impact of comorbid HIV on receipt of timely and complete neoadjuvant and adjuvant chemotherapy.Since June 2015, the SABCHO study has collected data on women diagnosed with breast cancer at 6 South African hospitals. We selected a sample of participants with stages I-III cancer who received ≥2 doses of neoadjuvant or adjuvant chemotherapy. Data on chemotherapies prescribed and received, filgrastim receipt, and laboratory values measured during treatment were captured from patients' medical records. We calculated the mean relative dose intensity (RDI) for all prescribed chemotherapies. We tested for association between full regimen RDI and HIV status, using linear regression to control for demographic and clinical covariates, and for association of HIV with laboratory abnormalities.The 166 participants living with HIV and 159 without HIV did not differ in median chemotherapy RDI: 0.89 (interquartile range (IQR) 0.77-0.95) among those living with HIV and 0.87 (IQR 0.77-0.94) among women without HIV. Patients living with HIV experienced more grade 3+ anemia and leukopenia than those without HIV (anemia: 10.8% vs. 1.9%, P = .001; leukopenia: 8.4% vs. 1.9%, P = .008) and were more likely to receive filgrastim (24.7% vs. 10.7%, P = .001).HIV status did not impact neoadjuvant or adjuvant chemotherapy RDI, although patients with breast cancer living with HIV experienced more myelotoxicity during treatment." @default.
• W4328049239 created "2023-03-22" @default.
• W4328049239 creator A5002890105 @default.
• W4328049239 creator A5009379894 @default.
• W4328049239 creator A5010081716 @default.
• W4328049239 creator A5021050968 @default.
• W4328049239 creator A5021106143 @default.
• W4328049239 creator A5028584651 @default.
• W4328049239 creator A5029628786 @default.
• W4328049239 creator A5030948193 @default.
• W4328049239 creator A5040735233 @default.
• W4328049239 creator A5045904328 @default.
• W4328049239 creator A5048406793 @default.
• W4328049239 creator A5051277039 @default.
• W4328049239 creator A5067512798 @default.
• W4328049239 creator A5068401391 @default.
• W4328049239 creator A5082136054 @default.
• W4328049239 creator A5082554584 @default.
• W4328049239 creator A5083003685 @default.
• W4328049239 creator A5091396460 @default.
• W4328049239 date "2023-03-21" @default.
• W4328049239 modified "2023-10-18" @default.
• W4328049239 title "The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer" @default.
• W4328049239 cites W1804059878 @default.
• W4328049239 cites W1981040752 @default.
• W4328049239 cites W2006070721 @default.
• W4328049239 cites W2046463525 @default.
• W4328049239 cites W2055543087 @default.
• W4328049239 cites W2093274439 @default.
• W4328049239 cites W2111225997 @default.
• W4328049239 cites W2118954661 @default.
• W4328049239 cites W2127129197 @default.
• W4328049239 cites W2142534753 @default.
• W4328049239 cites W2148422519 @default.
• W4328049239 cites W2149876820 @default.
• W4328049239 cites W2463860826 @default.
• W4328049239 cites W2560367415 @default.
• W4328049239 cites W2606920283 @default.
• W4328049239 cites W2612724718 @default.
• W4328049239 cites W2614048460 @default.
• W4328049239 cites W2771978163 @default.
• W4328049239 cites W2784834470 @default.
• W4328049239 cites W2791443656 @default.
• W4328049239 cites W2800837263 @default.
• W4328049239 cites W2868143915 @default.
• W4328049239 cites W2903535361 @default.
• W4328049239 cites W2915774478 @default.
• W4328049239 cites W2943800885 @default.
• W4328049239 cites W2965248506 @default.
• W4328049239 cites W2991532691 @default.
• W4328049239 cites W2993493576 @default.
• W4328049239 cites W2998394393 @default.
• W4328049239 cites W3009936153 @default.
• W4328049239 cites W3061102166 @default.
• W4328049239 cites W3081921407 @default.
• W4328049239 cites W3118967842 @default.
• W4328049239 cites W4214491611 @default.
• W4328049239 cites W4280565996 @default.
• W4328049239 doi "https://doi.org/10.1093/oncolo/oyad056" @default.
• W4328049239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36943395" @default.
• W4328049239 hasPublicationYear "2023" @default.
• W4328049239 type Work @default.
• W4328049239 citedByCount "0" @default.
• W4328049239 crossrefType "journal-article" @default.
• W4328049239 hasAuthorship W4328049239A5002890105 @default.
• W4328049239 hasAuthorship W4328049239A5009379894 @default.
• W4328049239 hasAuthorship W4328049239A5010081716 @default.
• W4328049239 hasAuthorship W4328049239A5021050968 @default.
• W4328049239 hasAuthorship W4328049239A5021106143 @default.
• W4328049239 hasAuthorship W4328049239A5028584651 @default.
• W4328049239 hasAuthorship W4328049239A5029628786 @default.
• W4328049239 hasAuthorship W4328049239A5030948193 @default.
• W4328049239 hasAuthorship W4328049239A5040735233 @default.
• W4328049239 hasAuthorship W4328049239A5045904328 @default.
• W4328049239 hasAuthorship W4328049239A5048406793 @default.
• W4328049239 hasAuthorship W4328049239A5051277039 @default.
• W4328049239 hasAuthorship W4328049239A5067512798 @default.
• W4328049239 hasAuthorship W4328049239A5068401391 @default.
• W4328049239 hasAuthorship W4328049239A5082136054 @default.
• W4328049239 hasAuthorship W4328049239A5082554584 @default.
• W4328049239 hasAuthorship W4328049239A5083003685 @default.
• W4328049239 hasAuthorship W4328049239A5091396460 @default.
• W4328049239 hasBestOaLocation W43280492391 @default.
• W4328049239 hasConcept C119060515 @default.
• W4328049239 hasConcept C121608353 @default.
• W4328049239 hasConcept C126322002 @default.
• W4328049239 hasConcept C141071460 @default.
• W4328049239 hasConcept C143998085 @default.
• W4328049239 hasConcept C2776694085 @default.
• W4328049239 hasConcept C2778248108 @default.
• W4328049239 hasConcept C2778336483 @default.
• W4328049239 hasConcept C2780873365 @default.
• W4328049239 hasConcept C2781413609 @default.
• W4328049239 hasConcept C530470458 @default.
• W4328049239 hasConcept C71924100 @default.
• W4328049239 hasConceptScore W4328049239C119060515 @default.
• W4328049239 hasConceptScore W4328049239C121608353 @default.
• W4328049239 hasConceptScore W4328049239C126322002 @default.

• next